Cannabis legalization measures will go before voters in five U.S. states on election day, Nov. 8, as the industry continues to grow. While smaller in population than many other U.S. Read more
Tag: AdvisorShares Pure US Cannabis ETF
Dow books 630-point drop after strong jobs data rattles investors, but stocks cement weekly gains
U.S. stocks finished sharply lower Friday, but still booked their best weekly gains in a month, after September jobs data showed an unexpected fall in the unemployment rate that’s anticipated Read more
Cannabis stocks rocketed to record day after Biden lit the fuse
Cannabis stocks shot to record gains Thursday after President Joe Biden formally sought to review how marijuana is classified under federal law, a change that pot companies in the U.S. Read more
Analyst slashes revenue outlook for Trulieve, Curaleaf, Canopy, Cronos as cannabis business takes a hit
Jefferies analyst Owen Bennett trimmed revenue expectations for four major cannabis names from the U.S. and Canada, but kept his ratings intact on the heels of quarterly updates from Curaleaf Read more
Trulieve trims view as inflation hits cannabis prospects
Trulieve Cannabis Corp. on Wednesday swung to a loss and cut its revenue outlook for the year as inflation impacted its prospects and softness in wholesale markets weighed on results. Read more
Curaleaf CEO sees cannabis as recession resistant, but stock falls after wider loss
Curaleaf Holdings Inc. Chief Executive Matt Darin said inflation impacted some of the cannabis company’s customers, but it still managed to beat its revenue target despite a wider quarterly loss. Read more
Green Thumb Industries notches eighth profitable quarter in a row in U.S. cannabis
Green Thumb Industries Inc. navigated a more uncertain economic environment and managed to beat Wall Street estimates with its eighth quarterly profit in a row. The cannabis company active in Read more
Seaport Global touts discounted cannabis stocks as a recession play
Seaport Global Securities LLC analyst Sonny Randhawa on Friday launched coverage of eight U.S. cannabis companies and assigned buy ratings to all of them as an undervalued group. He predicted Read more
Analysts see no lift for downbeat cannabis stocks from Chuck Schumer’s bill
An ambitious and long-awaited cannabis bill from Senate Majority Leader Chuck Schumer is unlikely to pass and will not likely stoke interest in U.S. cannabis stocks, analysts say. While the Read more
Chuck Schumer leads wide-ranging Senate bill to remove cannabis from federal list of controlled substances
Sen. Chuck Schumer on Thursday introduced a bill to tax and regulate cannabis and remove it from the federal list of controlled substances, but while it’ll open up the marijuana Read more